Diagnostic microbiology and infectious disease · 2026
Survey on relationship between microbiological laboratories and ICUs in France.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lepape Alain, Machut Anaïs, Vacheron Charles-Hervé, Elias Christelle, Prevot Claire, Bourge Xavier, Savey Anne, Friggeri Arnaud
Аннотация
INTRODUCTION: The interactions between intensive care units (ICUs) and microbiology laboratories are crucial with regard to their possible impact on antibiotic stewardship.
METHODS: A national survey was conducted in 2023 among ICUs participating in the REA-REZO surveillance network, which is dedicated to ICU-associated infections in adult units in France. Each unit was invited to complete a web-based questionnaire concerning the organisation, bacteriological techniques, workflow, and antibiotic policy.
RESULTS: A total of 84 units (response rate: 66.7%) responded to the survey (24 university public hospitals, 52 other public hospitals, 8 private hospitals). Samples have to be transported outside the hospital in 17.9% of units. Screening of multidrug-resistant bacterial colonisation is performed for methicillin-resistant S aureus in 94.0% of units, vancomycin-resistant Enterococcus in 85.7%, ESBL in 95.4%, and carbapenem-resistant Enterobacterales in 92.9%. Systematic analysis of removed catheters is done in 57.1% of units; less frequently for bronchial secretions (16.1%). Units have access to rapid diagnostic tests for diagnosis of infections such as multiplex PCR, which are available in 88% of units for pneumonia. Mass spectrometry was not available in 19% of units. Most units (66.7%) have an intensivist referent for infections. Computerised antimicrobial prescription is available in 75% of units, protocols are available in 56%, local bacterial ecology is available in 75%, and regular meetings with ID physicians in 56% of units.
CONCLUSIONS: Many new technologies that reduce the time between the onset of symptoms and targeted treatment are available in ICUs. The interface between ICUs and microbiology could be improved.
METHODS: A national survey was conducted in 2023 among ICUs participating in the REA-REZO surveillance network, which is dedicated to ICU-associated infections in adult units in France. Each unit was invited to complete a web-based questionnaire concerning the organisation, bacteriological techniques, workflow, and antibiotic policy.
RESULTS: A total of 84 units (response rate: 66.7%) responded to the survey (24 university public hospitals, 52 other public hospitals, 8 private hospitals). Samples have to be transported outside the hospital in 17.9% of units. Screening of multidrug-resistant bacterial colonisation is performed for methicillin-resistant S aureus in 94.0% of units, vancomycin-resistant Enterococcus in 85.7%, ESBL in 95.4%, and carbapenem-resistant Enterobacterales in 92.9%. Systematic analysis of removed catheters is done in 57.1% of units; less frequently for bronchial secretions (16.1%). Units have access to rapid diagnostic tests for diagnosis of infections such as multiplex PCR, which are available in 88% of units for pneumonia. Mass spectrometry was not available in 19% of units. Most units (66.7%) have an intensivist referent for infections. Computerised antimicrobial prescription is available in 75% of units, protocols are available in 56%, local bacterial ecology is available in 75%, and regular meetings with ID physicians in 56% of units.
CONCLUSIONS: Many new technologies that reduce the time between the onset of symptoms and targeted treatment are available in ICUs. The interface between ICUs and microbiology could be improved.